Catherine Spear - Aug 12, 2025 Form 4 Insider Report for FIGS, Inc. (FIGS)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Danielle Warner as Attorney-in-Fact for Catherine Spear
Stock symbol
FIGS
Transactions as of
Aug 12, 2025
Transactions value $
-$453,158
Form type
4
Date filed
8/14/2025, 04:39 PM
Previous filing
Mar 6, 2025
Next filing
Oct 6, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Spear Catherine Eva Chief Executive Officer, Director, 10%+ Owner C/O FIGS, INC., 2834 COLORADO AVENUE, SUITE 100, SANTA MONICA /s/ Danielle Warner as Attorney-in-Fact for Catherine Spear 2025-08-14 0001820448

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FIGS Class A Common Stock Sale -$453K -65.9K -3.24% $6.88 1.97M Aug 13, 2025 Direct F1, F2
holding FIGS Class A Common Stock 797K Aug 12, 2025 Held by the Catherine Spear Revocable Trust
holding FIGS Class A Common Stock 141 Aug 12, 2025 Held by Hollywood Capital Partners LLC F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FIGS Stock Option (Right to Buy) Disposed to Issuer -727K -100% 0 Aug 12, 2025 Class A Common Stock 727K $22.00 Direct F4, F5
transaction FIGS Stock Option (Right to Buy) Award +727K 727K Aug 12, 2025 Class A Common Stock 727K $6.63 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 REPRESENTS THE AGGREGATE NUMBER OF SHARES SOLD BY THE REPORTING PERSON SOLELY TO COVER REQUIRED TAXES AND FEES DUE UPON THE VESTING AND SETTLEMENT OF RESTRICTED STOCK UNITS ("RSUs"). THE SALES WERE MADE PURSUANT TO A 10B5-1 INSTRUCTION LETTER DELIVERED TO THE ISSUER ON MAY 13, 2025, AND NONE OF THE SHARES REPORTED AS SOLD ON THIS FORM 4 WERE SOLD FOR ANY REASON OTHER THAN TO COVER REQUIRED TAXES AND FEES.
F2 1,460,886 of these securities are RSUs, each representing a contingent right to receive one share of the Issuer's Class A Common Stock. In addition to the securities reported in this column, the Reporting Person holds 5,469,161 shares of the Issuer's Class B Common Stock directly and indirectly through various trusts, which are convertible at any time at the option of the Reporting Person into an equal number of shares of Class A Common Stock, and 18,958,606 shares of the Issuer's Class A Common Stock underlying vested options, neither of which are reported on this Form 4.
F3 The Reporting Person is a managing member of Hollywood Capital Partners LLC and disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
F4 All shares underlying this option have vested.
F5 The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on August 12, 2025 (the "Repricing Date"). The Option Repricing applies to 727,097 fully vested options originally granted to the Reporting Person on May 26, 2021 with an original exercise price of $22.00. Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $6.63 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. The vesting schedule of the repriced options has also been extended as reported herein. There is no change to the expiration date of, or number of shares underlying, the repriced options. For more information, see Part II, Item 5. "Other Information" in the Issuer's Form 10-Q filed with the SEC on August 7, 2025.
F6 The option vests and becomes exercisable in 24 equal monthly installments, with the first installment vesting on September 12, 2025.